Expeditors International Analyst Price Targets

Wall Street analyst price targets and consensus rating for Expeditors International (EXPD).

Price Target Range — 13 Quarters

Analyst Consensus — 15 Analysts

2Buy

9Hold

4Sell

Consensus RatingNeutral# Analysts15Avg. Consensus PT$164Upside to Avg. PT-14.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 2, 2026	UBS	Thomas Wadewitz	PT Raise	Buy	$210→$220
Oct 1, 2026	Baird	Daniel Moore	PT Raise	Neutral	$190→$200
Sep 30, 2026	BNP Paribas	Hugo Watkins	Initiate	Neutral	$180
Sep 29, 2026	Barclays	Brandon Oglenski	PT Raise	Underweight	$160→$165
Aug 5, 2026	UBS	Thomas Wadewitz	PT Raise	Buy	$191→$210
Aug 5, 2026	TD Cowen	Jason Seidl	PT Raise	Sell	$148→$176
Aug 5, 2026	Barclays	Brandon Oglenski	PT Raise	Underweight	$150→$160
Aug 5, 2026	JP Morgan	Brian Ossenbeck	Upgrade	Underweight→Neutral	$200
Jul 21, 2026	B of A Securities	Ken Hoexter	PT Raise	Buy	$181→$189
Jul 15, 2026	Citizens	Jeff Kauffman	Initiate	Market Perform	—
Jul 15, 2026	Truist Securities	Lucas Servera	PT Raise	Hold	$145→$175
Jul 15, 2026	Stifel	J. Bruce Chan	PT Raise	Hold	$154→$158
Jul 9, 2026	UBS	Thomas Wadewitz	PT Raise	Buy	$175→$191
Jun 25, 2026	Barclays	Brandon Oglenski	PT Raise	Underweight	$135→$150
May 8, 2026	UBS	Thomas Wadewitz	PT Raise	Buy	$166→$175
May 6, 2026	JP Morgan	Brian Ossenbeck	PT Raise	Underweight	$135→$139
May 6, 2026	Susquehanna	Bascome Majors	PT Raise	Neutral	$142→$156
Feb 26, 2026	Freedom Broker	Sergey Glinyanov	PT Raise	Hold	$124→$144
Feb 25, 2026	Truist Securities	Lucas Servera	PT Cut	Hold	$160→$140
Feb 25, 2026	Susquehanna	Bascome Majors	PT Cut	Neutral	$160→$142

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Maintains Buy on Expeditors International, Raises Price Target to $220

UBS analyst Thomas Wadewitz maintains Expeditors International (NYSE:EXPD) with a Buy and raises the price target from $210 to $220.

Benzinga Newsdesk

PRO
Baird Maintains Neutral on Expeditors International, Raises Price Target to $200

Baird analyst Daniel Moore maintains Expeditors International (NYSE:EXPD) with a Neutral and raises the price target from $190 to $200.

Benzinga Newsdesk

This Ciena Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Analysts initiated coverage: Buy on FORM ($200), NUVB ($12); Outperform on CIEN ($440); Neutral on EXPD ($180); Equal-Weight on SFD ($22).

Avi Kapoor

PRO
BNP Paribas Initiates Coverage On Expeditors International with Neutral Rating, Announces Price Target of $180

BNP Paribas analyst Hugo Watkins initiates coverage on Expeditors International (NYSE:EXPD) with a Neutral rating and announces Price Target of $180.

Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Expeditors International, Raises Price Target to $165

Barclays analyst Brandon Oglenski maintains Expeditors International (NYSE:EXPD) with a Underweight and raises the price target from $160 to $165.

Benzinga Newsdesk

PRO
CNBC Halftime Report Final Trades: AstraZeneca, Leidos Holdings, Expeditors International of Washington, U.S. 10 Year Treasury

Benzinga Newsdesk

Expeditors International of Washington Inc

Expeditors International Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
UBS Maintains Buy on Expeditors International, Raises Price Target to $220

PRO
Baird Maintains Neutral on Expeditors International, Raises Price Target to $200

This Ciena Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PRO
BNP Paribas Initiates Coverage On Expeditors International with Neutral Rating, Announces Price Target of $180

PRO
Barclays Maintains Underweight on Expeditors International, Raises Price Target to $165

PRO
CNBC Halftime Report Final Trades: AstraZeneca, Leidos Holdings, Expeditors International of Washington, U.S. 10 Year Treasury

People Also Watch

People Also Watch

Expeditors International of Washington Inc

Expeditors International Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROUBS Maintains Buy on Expeditors International, Raises Price Target to $220

PROBaird Maintains Neutral on Expeditors International, Raises Price Target to $200

This Ciena Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PROBNP Paribas Initiates Coverage On Expeditors International with Neutral Rating, Announces Price Target of $180

PROBarclays Maintains Underweight on Expeditors International, Raises Price Target to $165

PROCNBC Halftime Report Final Trades: AstraZeneca, Leidos Holdings, Expeditors International of Washington, U.S. 10 Year Treasury

People Also Watch

People Also Watch

PRO
UBS Maintains Buy on Expeditors International, Raises Price Target to $220

PRO
Baird Maintains Neutral on Expeditors International, Raises Price Target to $200

PRO
BNP Paribas Initiates Coverage On Expeditors International with Neutral Rating, Announces Price Target of $180

PRO
Barclays Maintains Underweight on Expeditors International, Raises Price Target to $165

PRO
CNBC Halftime Report Final Trades: AstraZeneca, Leidos Holdings, Expeditors International of Washington, U.S. 10 Year Treasury